| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
|
Richter, Franziska
|
|
2017
|
14 |
4 |
p. 1107-1119
|
artikel
|
| 2 |
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
|
Richter, Franziska
|
|
|
14 |
4 |
p. 1107-1119
|
artikel
|
| 3 |
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
|
Sormani, Maria Pia
|
|
2017
|
14 |
4 |
p. 924-933
|
artikel
|
| 4 |
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
|
Sormani, Maria Pia
|
|
|
14 |
4 |
p. 924-933
|
artikel
|
| 5 |
Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
|
McGinley, Marisa
|
|
2017
|
14 |
4 |
p. 985-998
|
artikel
|
| 6 |
Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
|
McGinley, Marisa
|
|
|
14 |
4 |
p. 985-998
|
artikel
|
| 7 |
Can a Neurosteroid Ameliorate Fragile X-Associated Tremor/Ataxia Syndrome?
|
Budimirovic, Dejan B.
|
|
2017
|
14 |
4 |
p. 1070-1072
|
artikel
|
| 8 |
Can a Neurosteroid Ameliorate Fragile X-Associated Tremor/Ataxia Syndrome?
|
Budimirovic, Dejan B.
|
|
|
14 |
4 |
p. 1070-1072
|
artikel
|
| 9 |
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice
|
Kantor, Sandor
|
|
2017
|
14 |
4 |
p. 1120-1133
|
artikel
|
| 10 |
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice
|
Kantor, Sandor
|
|
|
14 |
4 |
p. 1120-1133
|
artikel
|
| 11 |
Cladribine to Treat Relapsing Forms of Multiple Sclerosis
|
Giovannoni, Gavin
|
|
2017
|
14 |
4 |
p. 874-887
|
artikel
|
| 12 |
Cladribine to Treat Relapsing Forms of Multiple Sclerosis
|
Giovannoni, Gavin
|
|
|
14 |
4 |
p. 874-887
|
artikel
|
| 13 |
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
|
Miralles, Marta
|
|
2017
|
14 |
4 |
p. 1095-1106
|
artikel
|
| 14 |
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
|
Miralles, Marta
|
|
|
14 |
4 |
p. 1095-1106
|
artikel
|
| 15 |
Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
|
Baldassari, Laura E.
|
|
2017
|
14 |
4 |
p. 842-858
|
artikel
|
| 16 |
Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
|
Baldassari, Laura E.
|
|
|
14 |
4 |
p. 842-858
|
artikel
|
| 17 |
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
|
Williamson, Eric M. L.
|
|
2017
|
14 |
4 |
p. 961-973
|
artikel
|
| 18 |
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
|
Williamson, Eric M.L.
|
|
|
14 |
4 |
p. 961-973
|
artikel
|
| 19 |
Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA
|
Hartung, Daniel M.
|
|
2017
|
14 |
4 |
p. 1018-1026
|
artikel
|
| 20 |
Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA
|
Hartung, Daniel M.
|
|
|
14 |
4 |
p. 1018-1026
|
artikel
|
| 21 |
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study
|
Coler-Reilly, Ariella L. G.
|
|
2017
|
14 |
4 |
p. 1084-1094
|
artikel
|
| 22 |
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study
|
Coler-Reilly, Ariella L.G.
|
|
|
14 |
4 |
p. 1084-1094
|
artikel
|
| 23 |
Erratum to: Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice
|
Kantor, Sandor
|
|
2017
|
14 |
4 |
p. 1166
|
artikel
|
| 24 |
Erratum to: Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice
|
Kantor, Sandor
|
|
|
14 |
4 |
p. 1166
|
artikel
|
| 25 |
Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics
|
Amezcua, Lilyana
|
|
2017
|
14 |
4 |
p. 945-951
|
artikel
|
| 26 |
Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics
|
Amezcua, Lilyana
|
|
|
14 |
4 |
p. 945-951
|
artikel
|
| 27 |
Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
|
Nowinski, Cindy J.
|
|
2017
|
14 |
4 |
p. 934-944
|
artikel
|
| 28 |
Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
|
Nowinski, Cindy J.
|
|
|
14 |
4 |
p. 934-944
|
artikel
|
| 29 |
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model
|
Leo, Antonio
|
|
2017
|
14 |
4 |
p. 1134-1147
|
artikel
|
| 30 |
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model
|
Leo, Antonio
|
|
|
14 |
4 |
p. 1134-1147
|
artikel
|
| 31 |
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
|
Atkins, Harold L.
|
|
2017
|
14 |
4 |
p. 888-893
|
artikel
|
| 32 |
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
|
Atkins, Harold L.
|
|
|
14 |
4 |
p. 888-893
|
artikel
|
| 33 |
Letter From the Editor-in-Chief: Journal Transition in the Digital Age
|
Mouradian, M. Maral
|
|
2017
|
14 |
4 |
p. 831
|
artikel
|
| 34 |
Letter From the Editor-in-Chief: Journal Transition in the Digital Age
|
Mouradian, M. Maral
|
|
|
14 |
4 |
p. 831
|
artikel
|
| 35 |
Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead
|
Conway, Devon S.
|
|
2017
|
14 |
4 |
p. 832-834
|
artikel
|
| 36 |
Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead
|
Conway, Devon S.
|
|
|
14 |
4 |
p. 832-834
|
artikel
|
| 37 |
National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
|
Cywin, Charles L.
|
|
2017
|
14 |
4 |
p. 1066-1069
|
artikel
|
| 38 |
National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
|
Cywin, Charles L.
|
|
|
14 |
4 |
p. 1066-1069
|
artikel
|
| 39 |
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
|
Gelfand, Jeffrey M.
|
|
2017
|
14 |
4 |
p. 835-841
|
artikel
|
| 40 |
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
|
Gelfand, Jeffrey M.
|
|
|
14 |
4 |
p. 835-841
|
artikel
|
| 41 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome
|
Wang, J. Y.
|
|
2017
|
14 |
4 |
p. 1073-1083
|
artikel
|
| 42 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome
|
Wang, J.Y.
|
|
|
14 |
4 |
p. 1073-1083
|
artikel
|
| 43 |
Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding
|
Voskuhl, Rhonda
|
|
2017
|
14 |
4 |
p. 974-984
|
artikel
|
| 44 |
Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding
|
Voskuhl, Rhonda
|
|
|
14 |
4 |
p. 974-984
|
artikel
|
| 45 |
Remyelinating Pharmacotherapies in Multiple Sclerosis
|
Bove, Riley M.
|
|
2017
|
14 |
4 |
p. 894-904
|
artikel
|
| 46 |
Remyelinating Pharmacotherapies in Multiple Sclerosis
|
Bove, Riley M.
|
|
|
14 |
4 |
p. 894-904
|
artikel
|
| 47 |
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
|
Chaudhry, Burhan Z.
|
|
2017
|
14 |
4 |
p. 859-873
|
artikel
|
| 48 |
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
|
Chaudhry, Burhan Z.
|
|
|
14 |
4 |
p. 859-873
|
artikel
|
| 49 |
Therapeutic Approaches for Zika Virus Infection of the Nervous System
|
Abrams, Rachel P. M.
|
|
2017
|
14 |
4 |
p. 1027-1048
|
artikel
|
| 50 |
Therapeutic Approaches for Zika Virus Infection of the Nervous System
|
Abrams, Rachel P.M.
|
|
|
14 |
4 |
p. 1027-1048
|
artikel
|
| 51 |
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
|
Smith, Andrew L.
|
|
2017
|
14 |
4 |
p. 952-960
|
artikel
|
| 52 |
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
|
Smith, Andrew L.
|
|
|
14 |
4 |
p. 952-960
|
artikel
|
| 53 |
The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials
|
Mahajan, Kedar R.
|
|
2017
|
14 |
4 |
p. 905-923
|
artikel
|
| 54 |
The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials
|
Mahajan, Kedar R.
|
|
|
14 |
4 |
p. 905-923
|
artikel
|
| 55 |
The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
|
Luksik, Andrew S.
|
|
2017
|
14 |
4 |
p. 1049-1065
|
artikel
|
| 56 |
The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
|
Luksik, Andrew S.
|
|
|
14 |
4 |
p. 1049-1065
|
artikel
|
| 57 |
Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels
|
Kim, Yeri
|
|
2017
|
14 |
4 |
p. 1148-1165
|
artikel
|
| 58 |
Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels
|
Kim, Yeri
|
|
|
14 |
4 |
p. 1148-1165
|
artikel
|
| 59 |
Wellness and the Role of Comorbidities in Multiple Sclerosis
|
Moss, Brandon P.
|
|
2017
|
14 |
4 |
p. 999-1017
|
artikel
|
| 60 |
Wellness and the Role of Comorbidities in Multiple Sclerosis
|
Moss, Brandon P.
|
|
|
14 |
4 |
p. 999-1017
|
artikel
|
Tijdschrift beschrijving